DocSym
β
Searchsearch
Search
(C78.6) Secondary malignant neoplasm of retroperitoneum and peritoneum
More details coming soon
3 390 234 in individuals diagnosis secondary malignant neoplasm of retroperitoneum and peritoneum confirmed
417 883 deaths with diagnosis secondary malignant neoplasm of retroperitoneum and peritoneum
12% mortality rate associated with the disease secondary malignant neoplasm of retroperitoneum and peritoneum
Diagnosis secondary malignant neoplasm of retroperitoneum and peritoneum is diagnosed Men are 0.43% more likely than Women
1 702 431
Men receive the diagnosis secondary malignant neoplasm of retroperitoneum and peritoneum
219 527 (12.9 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
1 687 803
Women receive the diagnosis secondary malignant neoplasm of retroperitoneum and peritoneum
198 356 (11.8 %)Died from this diagnosis.
Risk Group for the Disease secondary malignant neoplasm of retroperitoneum and peritoneum - Men aged 65-69 and Women aged 60-64
In Men diagnosis is most often set at age 0-95+
Less common in men the disease occurs at Age 0-1Less common in women the disease occurs at Age 0-1
In Women diagnosis is most often set at age 0-95+
Disease Features secondary malignant neoplasm of retroperitoneum and peritoneum
Absence or low individual and public risk
Secondary malignant neoplasm of retroperitoneum and peritoneum - what does this mean
Secondary malignant neoplasm of retroperitoneum and peritoneum is a type of cancer that has spread from another area of the body to the retroperitoneum and peritoneum. it is typically caused by the spread of cancerous cells from a primary tumor located in another area of the body, such as the lungs, breast, or colon. treatment options depend on the type and stage of the cancer, as well as the patient's overall health.
What happens during the disease - secondary malignant neoplasm of retroperitoneum and peritoneum
Secondary malignant neoplasm of retroperitoneum and peritoneum is a type of cancer that develops from cells that have spread from a primary tumor in another part of the body. these cells travel through the bloodstream or lymphatic system and settle in the retroperitoneum or peritoneum, where they grow and form a tumor. this type of cancer can be difficult to treat, as the tumors can be located in hard-to-reach areas of the body.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Imaging tests such as CT scan, MRI, or PET scan
- Biopsy
- Blood tests to check for tumor markers
- Ultrasound
- Laparoscopy
- Endoscopy
Treatment and Medical Assistance
Main Goal: To reduce the size of the tumor and improve the patient's quality of life.
- Surgery to remove the tumor
- Radiation therapy to reduce tumor size
- Chemotherapy to inhibit tumor growth
- Hormone therapy to reduce hormone production
- Immunotherapy to enhance the body's immune response
- Targeted drug therapy to target specific tumor cells
- Nutrition and hydration to support the body's healing process
- Pain management to reduce discomfort
- Rehabilitation to improve mobility and strength
- Psychological support to help cope with the diagnosis
16 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Secondary malignant neoplasm of retroperitoneum and peritoneum - Prevention
The best way to prevent secondary malignant neoplasms of the retroperitoneum and peritoneum is to reduce the risk of developing the primary cancer. this can be done by avoiding smoking, maintaining a healthy diet, and exercising regularly. additionally, regular check-ups and screenings can help detect any signs of cancer early, allowing for prompt treatment and better outcomes.